Maxwell A J, Hanson I M, Sutton C J, Fitzgerald J, Pearson J M
Bolton Breast Unit, Royal Bolton Hospital, Minerva Road, Farnworth, Bolton, UK.
Breast. 2001 Oct;10(5):392-8. doi: 10.1054/brst.1999.0266.
One hundred and seventy eight cancers detected on incident round screening in the UK National Health Service Breast Screening Programme were reviewed. Critical review of the immediately preceding screening films (from 3 years previously) found abnormalities at the site of the subsequently detected cancer in 93 cases (52%). Forty-eight of these (27% of the total) had microcalcification as the sole abnormality. All of these 48 women had invasive ductal carcinoma and/or ductal carcinoma in situ (DCIS) (including four cases in which DCIS was associated with another type of primary invasive breast cancer). The finding of microcalcification on the previous mammograms at the site of a subsequently detected cancer was a strong predictor for the presence of DCIS (with or without associated invasive disease) (P<0.0001). Of the women with invasive ductal carcinoma, those with microcalcification on previous films were significantly more likely to have intermediate or high grade (grade 2 or 3) tumours than those women without microcalcification on previous films (P=0.0015). Previous films were also read blind by two independent experienced breast radiologists. Cancers were correctly identified by one or both readers in 39 cases. However, 35 of the remaining 139 cases showed microcalcification which was not detected or considered significant by the readers. If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015). These findings provide support for the hypothesis that microcalcification seen on previous screening films at the site of a subsequently detected invasive ductal carcinoma represents ductal carcinoma in situ. In this series, 19 of 82 women (23%) with invasive ductal carcinoma in the 'true negative' screen group had microcalcification suggestive of DCIS on mammograms taken, on average, 3 years previously. Significant microcalcification is often overlooked using current detection criteria. Early detection and treatment of DCIS is essential in order to prevent the development of aggressive invasive disease. Revision of the NHSBSP targets for DCIS detection is recommended.
对英国国家医疗服务体系乳腺筛查项目初次筛查时检测出的178例癌症进行了回顾。对紧接此前(3年前)的筛查影像进行严格审查后发现,在随后检测出癌症的部位有异常的病例有93例(52%)。其中48例(占总数的27%)的唯一异常为微钙化。这48名女性均患有浸润性导管癌和/或原位导管癌(DCIS)(包括4例DCIS与另一种原发性浸润性乳腺癌相关的病例)。在随后检测出癌症的部位,之前的乳房X光片上发现微钙化是DCIS(伴或不伴有相关浸润性疾病)存在的有力预测指标(P<0.0001)。在浸润性导管癌女性中,之前影像上有微钙化的患者比之前影像上没有微钙化的患者更有可能患有中级或高级(2级或3级)肿瘤(P=0.0015)。之前的影像还由两位经验丰富的独立乳腺放射科医生进行了盲法阅读。39例癌症被一位或两位阅片者正确识别。然而,在其余139例病例中,有35例显示出微钙化,但阅片者未检测到或认为不显著。如果仅分析这139例“真阴性”筛查,之前影像上的微钙化与随后发现的DCIS之间(P=0.03)以及之前影像上的微钙化与高级浸润性导管癌之间(P=0.015)也存在类似关联。这些发现支持了这样一种假设,即在随后检测出的浸润性导管癌部位,之前筛查影像上看到的微钙化代表原位导管癌。在这个系列中,“真阴性”筛查组中82例浸润性导管癌女性中有19例(23%)在平均3年前拍摄的乳房X光片上有提示DCIS的微钙化。使用当前的检测标准,显著的微钙化常常被忽视。DCIS的早期检测和治疗对于预防侵袭性疾病的发展至关重要。建议修订英国国家医疗服务体系乳腺筛查项目中DCIS检测的目标。